Articles by Michelle Hoffman - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Michelle Hoffman
« Previous
123456789
Next »

The Biopharmaceutical Manufacturing Survey

A Pharmaceutical Technology report looks at trends in biopharmaceutical manufacturing. This article contains bonus online-exclusive material.
Jul 2, 2009
By: Michelle Hoffman

A Pharmaceutical Technology report looks at trends in biopharmaceutical manufacturing. This article contains bonus online-exclusive material.

Truth and Transparency

Misleading the public about their investments—be it money or medicine—is unacceptable.
Jun 2, 2009
By: Michelle Hoffman

Misleading the public about their investments—be it money or medicine—is unacceptable.

Easing the Bottleneck

Manufacturers of therapeutic monoclonal antibodies consider new paradigms in purification technologies.
May 2, 2009
By: Michelle Hoffman

Manufacturers of therapeutic monoclonal antibodies consider new paradigms in purification technologies.

Parallel Tracks

Obama's cost-containment and science-innovation initiatives need to overlap.
Apr 2, 2009
By: Michelle Hoffman

Obama's cost-containment and science-innovation initiatives need to overlap.

Coming Down the Pike: Treating Epilepsy

Mar 2, 2009
By: Michelle Hoffman

Scientists studying epilepsy have traditionally focused on the comings and goings of ions through molecular channels in nerve cells, and many current antiseizure therapies seek to modulate that dynamic.

Whither FDA?

FDA's role should not be overlooked as it has been in years past.
Feb 2, 2009
By: Michelle Hoffman

FDA's role should not be overlooked as it has been in years past.

A New Start for New Cells

The incoming administration has renewed hope for stem cells, but less adequate copycats may follow.
Jan 2, 2009
By: Michelle Hoffman

The incoming administration has renewed hope for stem cells, but less adequate copycats may follow.

A Tale of Two Pharmaceutical Industries

China's quality approach to domestic versus exported products seems to be a lose-lose situation.
Dec 2, 2008
By: Michelle Hoffman

China's quality approach to domestic versus exported products seems to be a lose-lose situation.

Quality Counts

Pharma companies could benefit from the lessons learned in this fall's financial crisis.
Nov 2, 2008
By: Michelle Hoffman

Pharma companies could benefit from the lessons learned in this fall's financial crisis.

« Previous
123456789
Next »

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
44%
Facility/environment problems
0%
Process development problems
11%
Production equipment downtime
11%
Raw material supply problems
11%
Regulatory restrictions
0%
Business decisions to limit production
22%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here